Top Markets
Coin of the day
Nevro Corp. Nevro Corp.

Nevro Corp.

NVRO
株式のランク #17833
Nevro Corp. is a medical technology firm that delivers solutions for... Nevro Corp. is a medical technology firm that delivers solutions for individuals experiencing persistent pain, serving markets both domestically in the United States and across the globe. The company's core business involves the development and market introduction of the Senza spinal cord stimulation (SCS) system, an advanced, clinically supported neuromodulation platform specifically engineered to alleviate chronic pain. This portfolio encompasses its newer generations, the Senza II and Senza Omnia systems. Additionally, Nevro offers its proprietary 10 kHz Therapy, providing neuromodulation approaches grounded in robust clinical evidence for effective chronic pain management. Its products are distributed through a diverse strategy, utilizing a dedicated direct sales team complemented by a network of specialized sales agents and independent distributors. Founded in 2006, Nevro Corp. maintains its corporate headquarters in Redwood City, California.
株価
$5.84
最終同期: 2025-04-02
時価総額
$224.09M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Nevro Corp. (NVRO)

カテゴリー

Nevro Corp.(NVRO)の利益
Dec 2024 時点の利益 TTM: $-112.35M
Nevro Corp. の最新の財務報告によると、同社の現在の利益は $-112.35M です。2023 年には $-97.86M の利益を上げ、これは 2022 年の利益 $4.26M と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Nevro Corp. の利益の推移(2012 〜 2026)
各年末の利益
利益 変化
2026 (TTM) $-112.35M 0.00%
2024 $-112.35M 14.80%
2023 $-97.86M -2,395.00%
2022 $4.26M -103.26%
2021 $-130.83M 59.16%
2020 $-82.20M -19.48%
2019 $-102.09M 110.76%
2018 $-48.44M 37.41%
2017 $-35.25M 16.90%
2016 $-30.16M -54.49%
2015 $-66.27M 119.41%
2014 $-30.20M 17.74%
2013 $-25.65M 36.41%
2012 $-18.81M 0.00%
同業他社の利益
企業 利益 利益の差
$7.51B -6,785.60%
US
$5.15B -4,682.27%
US
$5.56B -5,051.67%
IE
$3.86B -3,536.70%
US
$1.42B -1,361.82%
US